|
Volumn 131, Issue 5, 2002, Pages 541-547
|
Prognostic value of thymidine phosphorylase/platelet-derived endothelial cell growth factor in advanced colorectal cancer after surgery: Evaluation with a new monoclonal antibody
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUOROURACIL;
FLUOROURACIL DERIVATIVE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY 1C6 203;
MONOCLONAL ANTIBODY 654 1;
PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR;
THYMIDINE PHOSPHORYLASE;
UFT;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CANCER INVASION;
CANCER STAGING;
CLINICAL FEATURE;
COLORECTAL CANCER;
COLORECTAL SURGERY;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE METASTASIS;
MALE;
PATHOLOGY;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
SENSITIVITY AND SPECIFICITY;
SURVIVAL RATE;
TUMOR DIFFERENTIATION;
|
EID: 0036257036
PISSN: 00396060
EISSN: None
Source Type: Journal
DOI: 10.1067/msy.2002.123804 Document Type: Article |
Times cited : (28)
|
References (30)
|